Key facts
- It has raised $2.5M; the latest was Early Stage VC ($2.5M) in Apr 2025.
- Notable investors include Evolution VC Partners, REFASHIOND Ventures, Expeditions Fund, Fulcrum Venture Group, Marengo Group. — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Larx
- ·The full record, as it builds
Funding rounds
No funding rounds for Larx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Larx
Operator of a comprehensive data orchestration and fusion platform intended to leverage AI to understand better and synthesize multi-domain information. The company's mission is to enable any user, regardless of technical competency, to convert data into actionable intelligence in the timeframes necessary to have strategic and operational effects, enabling people to turn fragmented imagery, video, and mission data into a single, trusted operational picture.
- Sector
- Information Technology
- HQ
- Atlanta, GA, United States
- Founded
- 2024
- Employees
- 14
- Website
- larx.io/
- Ownership
- Privately Held (backing)
Larx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Larx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Larx in its N-PORT filings yet. We sweep new filings monthly.